XML 27 R14.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Goodwill and Intangible Assets | 12 Months Ended
--- | ---
Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract] |
Goodwill and Intangible Assets | Goodwill and Intangible Assets Goodwill The changes in the carrying amount of goodwill are as follows:
| Automation and Analytics |  | Medication Adherence |  | Total
| (In thousands)
Net balance as of December 31, 2015 | $ | 54,316 |  |  | $ | 93,590 |  |  | $ | 147,906 |
Additions (1) | 163,599 |  |  | 20,832 |  |  | 184,431 |
Adjustments (2) | (2,833 | ) |  | (1,780 | ) |  | (4,613 | )
Net balance as of December 31, 2016 | 215,082 |  |  | 112,642 |  |  | 327,724 |
Additions (3) | 3,113 |  |  | 3,400 |  |  | 6,513 |
Adjustments (2) | 2,656 |  |  | 858 |  |  | 3,514 |
Net balance as of December 31, 2017 | $ | 220,851 |  |  | $ | 116,900 |  |  | $ | 337,751 |
_________________________________________________ (1) Additions to goodwill as a result of the Aesynt acquisition in January 2016 and Ateb acquisition in December 2016. (2) Adjustments reflect foreign currency exchange rate fluctuations. (3) Additions to goodwill in Automation and Analytics segment was a result of the InPharmics acquisition in April 2017. Additions to goodwill in Medication Adherence segment represent adjustments to the preliminary value assigned to goodwill in connection with Ateb acquisition to reflect measurement period adjustments related to accounts receivable, other non-current assets and other liabilities of $0.1 million, $0.7 million and $2.6 million, respectively. Intangible assets, net The carrying amounts of intangible assets and useful lives as of December 31, 2017 were as follows:
| December 31, 2017
| Gross carrying amount |  | Accumulated amortization |  | Foreign currency exchange rate fluctuations |  | Net carrying amount |  | Useful life (years)
| (In thousands, except for years)
Customer relationships | $ | 133,913 |  |  | $ | (33,526 | ) |  | $ | 65 |  |  | $ | 100,452 |  |  | 1 - 30
Acquired technology | 74,593 |  |  | (21,523 | ) |  | 34 |  |  | 53,104 |  |  | 3 - 20
Backlog | 21,712 |  |  | (17,544 | ) |  | — |  |  | 4,168 |  |  | 1 - 4
Trade names | 8,716 |  |  | (4,719 | ) |  | 6 |  |  | 4,003 |  |  | 1 - 12
Patents | 3,296 |  |  | (1,418 | ) |  | 2 |  |  | 1,880 |  |  | 2 - 20
Non-compete agreements | 1,900 |  |  | (1,300 | ) |  | — |  |  | 600 |  |  | 3
In process technology | 3,900 |  |  | — |  |  | — |  |  | 3,900 |  |  | -
Total intangibles assets, net | $ | 248,030 |  |  | $ | (80,030 | ) |  | $ | 107 |  |  | $ | 168,107 |  |  |
The carrying amounts of intangible assets and useful lives as of December 31, 2016 were as follows:
| December 31, 2016
| Gross carrying amount |  | Accumulated amortization |  | Foreign currency exchange rate fluctuations |  | Net carrying amount |  | Useful life (years)
| (In thousands, except for years)
Customer relationships | $ | 133,358 |  |  | $ | (20,930 | ) |  | $ | (596 | ) |  | $ | 111,832 |  |  | 1 - 30
Acquired technology | 73,599 |  |  | (13,287 | ) |  | (159 | ) |  | 60,153 |  |  | 3 - 20
Backlog | 20,550 |  |  | (14,083 | ) |  | — |  |  | 6,467 |  |  | 1 - 3
Trade names | 8,667 |  |  | (3,887 | ) |  | (31 | ) |  | 4,749 |  |  | 1 - 12
Patents | 3,154 |  |  | (1,264 | ) |  | — |  |  | 1,890 |  |  | 2 - 20
Non-compete agreements | 1,900 |  |  | (608 | ) |  | — |  |  | 1,292 |  |  | 3
In-process technology | 3,900 |  |  | — |  |  | — |  |  | 3,900 |  |  | -
Total intangibles assets, net | $ | 245,128 |  |  | $ | (54,059 | ) |  | $ | (786 | ) |  | $ | 190,283 |  |  |
Amortization expense of intangible assets was $25.6 million, $36.1 million and $6.9 million for the years ended December 31, 2017, December 31, 2016 and December 31, 2015, respectively. The estimated future amortization expenses for intangible assets are as follows:
For the year ended December 31, | (In thousands)
2018 | $ | 23,433 |
2019 | 17,953 |
2020 | 16,739 |
2021 | 15,439 |
2022 | 13,973 |
Thereafter (excluding in-process technology) | 76,670 |
Total | $ | 164,207 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration